Search Results 851-860 of 17052 for Hepatotoxicity

  1. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...

  2. Mitral valve regurgitation - Doctors and departments - Mayo Clinic

    Learn more about the symptoms and treatment of this most common heart valve condition, which causes blood to leak backward in the heart.

  3. Doctors and departments - Mayo Clinic

    High blood pressure (hypertension) and chronic kidney disease; Kidney disease and chronic liver disease; Genetics behind kidney diseases; Understanding what ...

  4. Polycystic kidney disease - Doctors and departments - Mayo Clinic

    The polycystic kidney and liver disease gene GANAB. Other genes that cause kidney cyst disease, such as DNAJB11. A way to use CT and MRI scans to classify ...

  5. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ vaccine featured image · Mayo Clinic Q&A podcast: US coronavirus map — what do the trends ...

  6. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer - Mayo Clinic

    About this study. The purpose of these phase I/II trial studies is to analyze the side effects and best dose of liposomal irinotecan and rucaparib when ...

  7. Echocardiographic Measures of Pulmonary Vascular Distensibility and Effects on Lung Diffusing Capacity - Mayo Clinic

    The purpose of this study is to determine if the change in pulmonary vascular compliance with positional changes (upright, supine, and Trendelenburg position) ...

  8. Triheptanoin (oral route) - Side effects & dosage - Mayo Clinic

    Triheptanoin is used to treat long-chain fatty acid oxidation disorders (LC-FAOD). LC-FAOD is a genetic metabolic disorder that prevents the body from breaking ...

  9. Assessment of Coronary Plaque Composition Using Optical Coherence Tomography - Mayo Clinic

    About this study. The investigators hypothesis is that local activation of the endogenous Lp-PLA2 plays an integral role in early atherosclerosis, ...

  10. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...